Cytosorbents Corp
CTSO
94 hedge funds and large institutions have $140M invested in Cytosorbents Corp in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 15 closing their positions.
52% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 21
8% more call options, than puts
Call options by funds: $665K | Put options by funds: $613K
3% more capital invested
Capital invested by funds: $136M → $140M (+$3.81M)
0.87% more ownership
Funds ownership: 39.84% → 40.71% (+0.87%)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
2% less funds holding
Funds holding: 96 → 94 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$2.77M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.72M |
| 3 |
AIC
AWM Investment Company
New York
|
+$1.67M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.47M |
| 5 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$885K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.39M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$632K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$542K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$523K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$507K |
CTSO Hedge Fund Activity: Q4 2020 in Review
94 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2020, worth a combined $140M — up 2.8% from $136M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of CTSO and 14 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 32 added.
The largest buyer was Neuberger Berman Group, adding an estimated $2.77M. The largest seller was Sectoral Asset Management, cutting an estimated $4.39M.
- 94 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2020, down from 96 in Q3 2020.
- Funds reported $140M of Cytosorbents Corp stock for Q4 2020, up 2.8% quarter-over-quarter.
- 14 funds opened new Cytosorbents Corp positions in Q4 2020 and 15 closed out, a net change of -1 holder.
- The largest Cytosorbents Corp buyer in Q4 2020 was Neuberger Berman Group, an estimated $2.77M added.
- The largest Cytosorbents Corp seller in Q4 2020 was Sectoral Asset Management, an estimated $4.39M sold.
Based on aggregated 13F filings for Q4 2020.